John Sylvester
Vermögen: 161 010 $ am 31.05.2026
Vermögen: 161 010 $ am 31.05.2026
John Richard Sylvester is currently Non-Executive Chairman at Delcath Systems, Inc. since 2023 and Chairman at Regatta Point (Freehold) Ltd. Former roles include CEO-SPECT & International Business at Curium Holding France SASU, Managing Director-Oncology Products Division at Biocompatibles International Ltd. from 2005 to 2019, Director at Provensis Ltd., Director at Biocompatibles UK Ltd. from 2005 to 2019, Non-Executive Director at Venture Life Group Plc from 2013 to 2018, General Manager-European & Asian Operations at Rio Tinto Plc, English China Clays Plc, and Imperial Chemical Industries Ltd., Chief Development Officer at BTG Ltd., and Vice President-Marketing at Baxter Healthcare SA. Education includes undergraduate studies at the University of Manchester Institute of Science & Technology.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 13.05.2026 | 14’936 ( 0.04% ) | 161 010 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| DELCATH SYSTEMS, INC. | Vorsitzender | 16.02.2023 |
Regatta Point (Freehold) Ltd. | Vorsitzender | 27.09.2010 |
| Unternehmen | Position | Ende |
|---|---|---|
Biocompatibles UK Ltd.
Biocompatibles UK Ltd. BiotechnologyHealth Technology Manufactures, and markets implantable products for patients | Direktor/Vorstandsmitglied | 19.08.2019 |
Biocompatibles International Ltd.
Biocompatibles International Ltd. Miscellaneous Commercial ServicesCommercial Services Produces drug device combination products | Corporate Officer/Principal | 19.08.2019 |
Provensis Ltd.
Provensis Ltd. Pharmaceuticals: MajorHealth Technology Manufactures polidocanol injectable foam | Direktor/Vorstandsmitglied | 19.08.2019 |
| VENTURE LIFE GROUP PLC | Direktor/Vorstandsmitglied | 20.09.2018 |
Curium Holding France SASU
Curium Holding France SASU Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies radiopharmaceutical products | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 13 |
|---|---|
Rio Tinto Plc
Rio Tinto Plc Other Metals/MineralsNon-Energy Minerals Explores and mines for mineral resources | Non-Energy Minerals |
English China Clays Plc
English China Clays Plc Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Imperial Chemical Industries Ltd.
Imperial Chemical Industries Ltd. Chemicals: Major DiversifiedProcess Industries Manufactures chemicals and paint products | Process Industries |
Delcath Systems, Inc.
Delcath Systems, Inc. Medical SpecialtiesHealth Technology Develops and manufactures drugs for treatment of cancer | Health Technology |
BTG Ltd.
BTG Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies drugs used in the treatment of neurological disorders | Health Technology |
Biocompatibles International Ltd.
Biocompatibles International Ltd. Miscellaneous Commercial ServicesCommercial Services Produces drug device combination products | Commercial Services |
Baxter Healthcare SA
Baxter Healthcare SA Pharmaceuticals: MajorHealth Technology Develops, manufactures, and distributes hospital supplies, medical technologies and pharmaceutical products | Health Technology |
University of Manchester Institute of Science & Technology
University of Manchester Institute of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Provensis Ltd.
Provensis Ltd. Pharmaceuticals: MajorHealth Technology Manufactures polidocanol injectable foam | Health Technology |
Regatta Point (Freehold) Ltd. | |
Biocompatibles UK Ltd.
Biocompatibles UK Ltd. BiotechnologyHealth Technology Manufactures, and markets implantable products for patients | Health Technology |
Venture Life Group Plc
Venture Life Group Plc Pharmaceuticals: MajorHealth Technology Manufactures and markets consumer healthcare & cosmetics products | Health Technology |
Curium Holding France SASU
Curium Holding France SASU Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies radiopharmaceutical products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen